From Trichilemmoma to Myxedema: Dermatopathology Case Review

Cockerell Dermatopathology

C. Cockerell

Molluscum Update (January 2024)

Elaine C. Siegfried

Management of Raynaud’s Phenomenon

John D. Pauling

Vasculitis Treatment Update

Keck School of Medicine of USC

K. Ruddy

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Year in Review: zOS Update Version 20.24.Z

Dermatology 2024 Year in Review

M. Zirwas

Practical Practice Pearls

Stephen Stone

What Every Dermatologist Should Know About Emergency Contraception

American Acne and Rosacea Society (AARS)

A. Zaenglein, S. K. Horvath

Deroofing in HS

Hidradenitis Suppurativa Foundation

S. Daveluy

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

Skin Signs of Systemic Disease: Addressing Non-Responders and Caring…

Dermatology Education Foundation (DEF)

B. Glick

Year in Review: Updates on Anti-Microbial Resistance for the Primary…

Dermatology 2024 Year in Review

T. Rosen

Systemic and Cutaneous Lupus Consideration

Masterclasses in Dermatology

J. Merola

Bullous Pemphigoid Updates (2024)

NYU Langone

P. Adotama

Hidradenitis Suppurativa: Starting Treatments

Hidradenitis Suppurativa Foundation

S. Daveluy

Dermatologic Toxicities to Immunotherapy

University of Louisville

A. Markova

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Rheumatology Update for the Generalist in 2024

McMaster University Department of Medicine

R. Mirza

Myths and Misconceptions ANCA Associated Vasculitis

RheumNow

M. Putman

AAD 2024 Insights: Practical Practice Pearls

AAD 2024

S. Stone